Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001062

Drug Information
SynonymsDibenz(b,e)oxepin-2-acetic acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; Allelock; Patanol; SMR000469220; Pataday; AC1NR00D; MolPort-003-986-254; CID5281071; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride; OLOPATADINE HCl; MLS001401465; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride; ALO4943A; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; L000748; CHEMBL1719; O0361; SAM001246802; AL-4943A; Olopatadine [INN:BAN]; Olopatadine; KW-4943A; 140462-76-6; CID5282402; DB00768; {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; TL8000403; AC1NQXZH; KW 4679; LS-61598; 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; S2494_Selleck; 113806-05-6; LS-172239; STK624184; Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; Opatanol; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; Patanase; ALO-4943A; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride; 113806-05-6 (Parent); KW-4679; CPD000469220; OLOPATADINE HYDROCHLORIDE; UNII-2XG66W44KF; 140462-76-6 (hydrochloride); TL8000904; MolPort-003-986-408; FT-0082377; BIDD:GT0285; HMS2089K10; Bio-0072; UNII-D27V6190PM; HCl of KW 4679; SBB066095    
Trade NamePataday; Patanol S; Patanase; Allelock    
IndicationAllergic conjunctivitisApproved    [1]
Ocular allergyPhase III    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntiallergic Agents    
CAS NumberCAS 113806-05-6
PubChem Compound IDCID 5281071.    
PubChem Substance IDSID 698647.    
SuperDrug ATC IDS01GX09;    
SuperDrug CAS ID113806056;    
TargetHistamine H1 receptorAntagonist[1]
Histamine H1 receptorAntagonist[2]
Ref 1Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. To Reference
Ref 2Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study. Clin Drug Investig. 2009;29(7):451-7. doi: 10.2165/00044011-200929070-00003. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543